TNFSF10 and hepatocellular carcinoma: Furthermore, melittin has been shown to sensitize HCC cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis, indicating its potential for use in combination regimens, especially for TRAIL-resistant tumors [10].